sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Covid-19 Impact on Global Opioids Market Research Report 2020

Covid-19 Impact on Global Opioids Market Research Report 2020

Home / Categories / Healthcare
Covid-19 Impact on Global Opioids Market Research Report 2020
Covid-19 Impact on Global Opioids...
Report Code
RO1/129/29060

Publish Date
07/Nov/2020

Pages
156
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioids Revenue
1.4 Market Analysis by Type
1.4.1 Global Opioids Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immediate-Release/Short-Acting Opioid
1.4.3 Extended-Release/Long-Acting Opioid
1.5 Market by Application
1.5.1 Global Opioids Market Share by Application: 2021-2026
1.5.2 Pain Relief
1.5.3 Anesthesia
1.5.4 Cough Suppression
1.5.5 Diarrhea Suppression
1.5.6 Deaddiction
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Opioids Market
1.8.1 Global Opioids Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Opioids Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Opioids Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Opioids Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Opioids Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Opioids Sales Volume Market Share by Region (2015-2020)
3.2 Global Opioids Sales Revenue Market Share by Region (2015-2020)
3.3 North America Opioids Sales Volume
3.3.1 North America Opioids Sales Volume Growth Rate (2015-2020)
3.3.2 North America Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Opioids Sales Volume
3.4.1 East Asia Opioids Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Opioids Sales Volume (2015-2020)
3.5.1 Europe Opioids Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Opioids Sales Volume (2015-2020)
3.6.1 South Asia Opioids Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Opioids Sales Volume (2015-2020)
3.7.1 Southeast Asia Opioids Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Opioids Sales Volume (2015-2020)
3.8.1 Middle East Opioids Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Opioids Sales Volume (2015-2020)
3.9.1 Africa Opioids Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Opioids Sales Volume (2015-2020)
3.10.1 Oceania Opioids Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Opioids Sales Volume (2015-2020)
3.11.1 South America Opioids Sales Volume Growth Rate (2015-2020)
3.11.2 South America Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Opioids Sales Volume (2015-2020)
3.12.1 Rest of the World Opioids Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Opioids Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Opioids Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Opioids Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Opioids Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Opioids Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Opioids Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Opioids Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Opioids Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Opioids Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Opioids Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Opioids Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Opioids Sales Volume Market Share by Type (2015-2020)
14.2 Global Opioids Sales Revenue Market Share by Type (2015-2020)
14.3 Global Opioids Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Opioids Consumption Volume by Application (2015-2020)
15.2 Global Opioids Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Opioids Business
16.1 Purdue Pharma L.P.
16.1.1 Purdue Pharma L.P. Company Profile
16.1.2 Purdue Pharma L.P. Opioids Product Specification
16.1.3 Purdue Pharma L.P. Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Pfizer, Inc.
16.2.1 Pfizer, Inc. Company Profile
16.2.2 Pfizer, Inc. Opioids Product Specification
16.2.3 Pfizer, Inc. Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 West-Ward Pharmaceuticals Corporation
16.3.1 West-Ward Pharmaceuticals Corporation Company Profile
16.3.2 West-Ward Pharmaceuticals Corporation Opioids Product Specification
16.3.3 West-Ward Pharmaceuticals Corporation Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Sun Pharmaceutical Industries Limited.
16.4.1 Sun Pharmaceutical Industries Limited. Company Profile
16.4.2 Sun Pharmaceutical Industries Limited. Opioids Product Specification
16.4.3 Sun Pharmaceutical Industries Limited. Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Allergan
16.5.1 Allergan Company Profile
16.5.2 Allergan Opioids Product Specification
16.5.3 Allergan Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Egalet Corporation
16.6.1 Egalet Corporation Company Profile
16.6.2 Egalet Corporation Opioids Product Specification
16.6.3 Egalet Corporation Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Janssen Pharmaceuticals, Inc.
16.7.1 Janssen Pharmaceuticals, Inc. Company Profile
16.7.2 Janssen Pharmaceuticals, Inc. Opioids Product Specification
16.7.3 Janssen Pharmaceuticals, Inc. Opioids Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Opioids Manufacturing Cost Analysis
17.1 Opioids Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Opioids
17.4 Opioids Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Opioids Distributors List
18.3 Opioids Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Opioids (2021-2026)
20.2 Global Forecasted Revenue of Opioids (2021-2026)
20.3 Global Forecasted Price of Opioids (2015-2026)
20.4 Global Forecasted Production of Opioids by Region (2021-2026)
20.4.1 North America Opioids Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Opioids Production, Revenue Forecast (2021-2026)
20.4.3 Europe Opioids Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Opioids Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Opioids Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Opioids Production, Revenue Forecast (2021-2026)
20.4.7 Africa Opioids Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Opioids Production, Revenue Forecast (2021-2026)
20.4.9 South America Opioids Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Opioids Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Opioids by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Opioids by Country
21.2 East Asia Market Forecasted Consumption of Opioids by Country
21.3 Europe Market Forecasted Consumption of Opioids by Countriy
21.4 South Asia Forecasted Consumption of Opioids by Country
21.5 Southeast Asia Forecasted Consumption of Opioids by Country
21.6 Middle East Forecasted Consumption of Opioids by Country
21.7 Africa Forecasted Consumption of Opioids by Country
21.8 Oceania Forecasted Consumption of Opioids by Country
21.9 South America Forecasted Consumption of Opioids by Country
21.10 Rest of the world Forecasted Consumption of Opioids by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com